VITAMIN D METABOLISM BY T CELL LYMPHOCYTES
T 细胞淋巴细胞的维生素 D 代谢
基本信息
- 批准号:3157354
- 负责人:
- 金额:$ 6.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-04-01 至 1989-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this project is to characterize the metabolism of vitamin D
by T-cell lymphocytes in vitro with particular attention to the production
of 1,25-dihydroxyvitamin D (1,25(OH)2D), the most active metabolite of
vitamin D. Preliminary results from the Principal Investigator's
laboratory indicate that HTLV-transformed cord blood lymphocytes have the
capacity to convert 25(OH)D to a more polar metabolite which coelutes with
authentic 1,25(OH)2D using two separate high performance liquid
chromatography systems and stimulates bone resorption in vitro.
Identification of this metabolite as 1,25(OH)2D by gas chromatography/mass
spectrometry suggest that these transformed lymphocytes have
1-alpha-hydroxylase activity. Since 1,25(OH)2D is a potent stimulator of
osteoclastic bone resorption, increased production of 1,25(OH)2D or other
vitamin D metabolites by lymphoma cells may play a role in the pathogenesis
of the increased osteoclastic bone resorption and hypercalcemia which occur
in this disease.
Accordingly, the purpose of this study is to use HTLV-transformed
lymphocytes as an in vitro model to study the metabolism of vitamin D by
lymphocytes in order to:
1. Characterize the metabolites of vitamin D which are produced by HTLV
transformed T-lymphocytes with particular attention to the production of
1,25(OH)2D.
2. Examine the metabolism of vitamin D by peripheral lymphocytes in
patients with other disease states characterized by abnormal lymphocyte
function and altered bone and mineral metabolism.
3. Determine if activated normal lymphocytes have 1-alpha-hydroxylase
activity.
4. Characterize the 1-alpha-hydroxylase activity in normal and abnormal
lymphocytes to see if it is regulated by the same factors which regulate
renal 1-alpha-hydroxylase activity.
These studies will determine whether or not the ability to produce
1,25(OH)2D is a general property of all activated lymphocytes or is a
unique property of lymphocytes infected with the HTLV virus. Moreover,
characterization of this 1-alpha-hydroxylase activity and identification of
those factors which regulate lymphocyte 1-alpha-hydroxylase activity will
provide important information concerning factors that control vitamin D
metabolism both in normal individuals and disease states characterized by
abnormal bone and mineral metabolism. These results will also form the
basis of studies designed to elucidate the molecular mechanisms responsible
for the activation of 1-alpha-hydroxylase activity in lymphocytes.
该项目的目的是描述维生素D的代谢
通过T细胞淋巴细胞在体外,特别注意生产
1,25-二羟维生素D(1,25(OH)2D),最活跃的代谢产物,
维生素D. 主要研究者的初步结果
实验室表明HTLV转化脐带血淋巴细胞具有
将25(OH)D转化为极性更强的代谢物的能力,
使用两种独立的高性能液体的正宗1,25(OH)2D
色谱系统和刺激骨吸收体外。
通过气相色谱/质谱法鉴别该代谢产物为1,25(OH)2D
光谱分析表明,这些转化的淋巴细胞
1-α-羟化酶活性。 由于1,25(OH)2D是一种有效的刺激剂,
骨细胞骨吸收,1,25(OH)2D或其他的产生增加
淋巴瘤细胞的维生素D代谢产物可能在发病机制中起作用
骨吸收和高钙血症的增加,
在这种疾病中。
因此,本研究的目的是使用HTLV转化的
淋巴细胞作为体外模型,研究维生素D的代谢,
淋巴细胞,以便:
1.表征HTLV产生的维生素D代谢产物
转化的T淋巴细胞,特别注意产生
1,25(OH)2D。
2.用外周血淋巴细胞检测维生素D的代谢
淋巴细胞异常的其他疾病状态患者
功能和改变骨和矿物质代谢。
3.确定活化的正常淋巴细胞是否具有1-α-羟化酶
活动
4.表征正常和异常中的1-α-羟化酶活性
淋巴细胞,看看它是否受到相同的因素调节,
肾1-α-羟化酶活性。
这些研究将决定是否有能力生产
1,25(OH)2D是所有活化淋巴细胞的一般性质,或者是一种
HTLV病毒感染的淋巴细胞的独特性质。 此外,委员会认为,
该1-α-羟化酶活性的表征和
调节淋巴细胞1-α-羟化酶活性的那些因子将
提供有关控制维生素D的因素的重要信息
在正常个体和疾病状态中的代谢,
骨骼和矿物质代谢异常。 这些结果也将形成
研究的基础,旨在阐明负责的分子机制
用于激活淋巴细胞中的1-α-羟化酶活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES F DUNN其他文献
JAMES F DUNN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES F DUNN', 18)}}的其他基金
CHARACTERIZATION OF A HUMAN OSTEOCLAST-LIKE CELL LINE
人类破骨细胞样细胞系的表征
- 批准号:
3154082 - 财政年份:1985
- 资助金额:
$ 6.08万 - 项目类别:
CHARACTERIZATION OF A HUMAN OSTEOCLAST-LIKE CELL LINE
人类破骨细胞样细胞系的表征
- 批准号:
3157306 - 财政年份:1985
- 资助金额:
$ 6.08万 - 项目类别:
CHARACTERIZATION OF A HUMAN OSTEOCLAST-LIKE CELL LINE
人类破骨细胞样细胞系的表征
- 批准号:
3157307 - 财政年份:1985
- 资助金额:
$ 6.08万 - 项目类别:
DIURNAL CHANGES IN PLASMA BINDING OF ALDOSTERONE AND CORTISOL
醛固酮和皮质醇血浆结合的每日变化
- 批准号:
4704595 - 财政年份:
- 资助金额:
$ 6.08万 - 项目类别:
1,25-DIHYDROXYVITAMIN D LEVELS IN HEALTH AND DISEASE
1,25-二羟基维生素 D 水平与健康和疾病的关系
- 批准号:
4704596 - 财政年份:
- 资助金额:
$ 6.08万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 6.08万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 6.08万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 6.08万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 6.08万 - 项目类别:
Discovery Grants Program - Individual